Navigation Links
Aware, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

BEDFORD, Mass., May 5 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its first quarter ended March 31, 2009.

Revenues for the first quarter of 2009 were $4.6 million, a decrease of 22% compared to $5.9 million in the same quarter last year.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

The GAAP net loss for the first quarter of 2009 was $2.1 million, or $0.09 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to a GAAP net loss of $1.3 million, or $0.05 per diluted share, for the same period a year ago.

The non-GAAP net loss for the first quarter of 2009, excluding the effect of stock-based compensation, was $1.7 million, or $0.07 per diluted share.

Michael Tzannes, Aware's chief executive officer, said, "We continued to experience slowdowns in our business as a result of the slowing economy during the first quarter. Our goal is to emerge from the current environment st
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
2. Aware, Inc. Announces Q1 09 Earnings Conference Call
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
5. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Commences Dutch Auction Tender Offer
8. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
9. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
10. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... Caesarean section have a different intestinal flora than children delivered ... is the case and what it means for the immune ... therefore decided to scrutinise the impact of birth on the ... mouse pups. , The study shows that ... of cells that strengthen the immune system, says Camilla Hartmann ...
(Date:7/9/2014)... switch out one gene for another in a line ... fiction to reality within this decade. As with any ... of fixing disease-causing genes in humans, for example--as well ... put one of those concerns to rest: using gene-editing ... of mutations in the cells. The new results were ...
(Date:7/9/2014)... deer hunts in Indiana state parks have helped restore ... caused by overabundant populations of white-tailed deer, a Purdue ... Jenkins, associate professor of forest ecology, found that a ... hunts in state parks has successfully spurred the regrowth ... by browsing deer. , Jenkins said that while ...
Breaking Biology News(10 mins):Mouse study: Natural birth may strengthen the immune system 2No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3Hunting gives deer-damaged forests in state parks a shot at recovery 2
... 12 surgeons and 21 surgical residents, video game skill ... a simulated surgery skills course, according to a report ... of the JAMA/Archives journals. , James C. Rosser Jr., ... colleagues asked 33 surgeons (21 residents and 12 attending ...
... speculated that lead poisoning may have played a role in ... have been caused by the concentration of grape juice in ... damage to the environment, the annual production of lead continues ... glass, and electronic components. However, there has thus far been ...
... made to retain naturally occurring compounds called flavanols may ... and chart the course for future research that could ... dementia, according to a panel of scientists who presented ... Association for the Advancement of Science (AAAS). , Several ...
Cached Biology News:Lead with a poisonous electron shield 2Flavanols in cocoa may offer benefits to the brain 2Flavanols in cocoa may offer benefits to the brain 3
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Two champions ... continued their sponsorship of an annual competition for middle ... and access to, innovative STEM study. The competition presents ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
(Date:1/15/2014)... 2014 TaiGen Biotechnology Company, Limited ("TaiGen") today announced ... a leading Russian pharmaceutical company, to develop and commercialize ... Federation , Turkey and ... a novel antibiotic for the treatment of bacterial infections ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... LLY ) today announced final results from a retrospective ... risk of acute pancreatitis among initiators of BYETTA® (exenatide) ... antidiabetic therapies. These findings were presented at the 70th ...
... N.C. , June 25 Ruedi Waeger , Ph.D., former ... Board of Directors, was honored with the Robert W. Reilly Leadership award ... . , , , ... the Plasma Protein Therapeutics Association (PPTA) and recognizes individuals who exemplify the leadership ...
... , CRANBURY, N.J. , June 25 Palatin ... has entered into definitive agreements with certain accredited investors to sell ... of $0.20 per unit for gross proceeds of ... expenses.  Each unit will consist of one share of common stock ...
Cached Biology Technology:Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 2Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 3Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 4Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 5Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 6Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 7Study Finds BYETTA(R) Use Was Not Associated With Increased Rate of Acute Pancreatitis Compared to Other Antidiabetic Drugs: Final Results Presented at ADA 2010 8Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association 2Palatin Technologies, Inc. to Raise $2.0 Million Dollars in Registered Direct Offering 2Palatin Technologies, Inc. to Raise $2.0 Million Dollars in Registered Direct Offering 3
GlutaMAX-I Supplement...
Chemically Defined Lipid Concentrate...
... Cell Dissociation Buffers are membrane-filtered isotonic ... chelating agents and cell-conditioning agents in ... salt solution or Ca2+- and ... of mammalian cells from support substrates ...
... g Blocking Reagent , 2 x 50 ml 10X ... , 0.2 ml BL21 glycerol stock , 0.2 ... stock , 1010 pfu T7Select Positive Control Lysate , ... l S-protein HRP Conjugate , 2 ml T7Select S-protein ...
Biology Products: